全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

不完全性川崎病合并嗜血细胞综合征1例临床报道并文献复习
Incomplete Kawasaki Disease Complicated with Hemophilic Syndrome: A Case Report and Literature Review

DOI: 10.12677/ACRP.2021.91001, PP. 1-7

Keywords: 不完全性川崎病,嗜血细胞综合征,诊断,治疗
Incomplete Kawasaki Disease
, Hemophagocytic Syndrome, Diagnosis, Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:了解不完全性川崎病合并嗜血细胞综合征的发生发展过程,提高对该疾病的认识和警惕。方法:回顾分析1例婴幼儿免疫球蛋白治疗无反应型不完全性川崎病合并嗜血细胞综合征的临床资料。结果:该2岁大男性患儿入院时符合不完全川崎病诊断,两次免疫球蛋白冲击治疗无效,仍反复高热,最后发展为嗜血细胞综合征,出现血常规提示3系下降、肝功能异常、血清铁蛋白升高等,骨髓细胞学检测可见噬血现象等,最后按HLH-04化疗方案治疗好转出院。结论:不完全性川崎病免疫球蛋白治疗无效,应早期激素或免疫抑制剂治疗,并提高对该病的早期识别及干预,早期阻断该病发展为嗜血细胞综合征。
Objective: To understand the occurrence and development of incomplete Kawasaki disease with the hemophagocytic syndrome, and to raise awareness and vigilance of the disease. Method: The clinical data of incomplete Kawasaki disease with the hemophagocytic syndrome in a 2-year-old boy was retrospectively analyzed. Results: We report here a case of a 2-year-old boy with incomplete Kawa-saki disease which resistant to two doses of immunoglobulins and have recurrent hyperthermia. Eventually develop into hemophagocytic syndrome, in which blood tests demonstrated blood rou-tine showed the decline of 3 lines, abnormal liver function, elevated serum ferritin, and hemopha-gocytosis features on bone marrow aspirate. Finally, recovery was obtained with the HLH-04 chem-otherapy regimen. Conclusion: When the immunoglobulin therapy for incomplete Kawasaki disease is ineffective, early glucocorticoid or immunosuppressive therapy should be used. Besides, we should improve the early recognition and intervention of the disease, and block the development of the disease into hemophagocytic syndrome.

References

[1]  Henter, J.I., Horne, A., Arico, M., et al. (2007) HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131.
https://doi.org/10.1002/pbc.21039
[2]  Score. http://saintantoine.aphp.fr/score
[3]  Ayusawa, M., Sonobe, T., Uemura, S., et al. (2005) Revision of Diagnostic Guidelines for Kawasaki Disease (the 5th Revised Edition). Pediatrics International, 47, 232-234.
https://doi.org/10.1111/j.1442-200x.2005.02033.x
[4]  McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Pro-fessionals from the American Heart Association. Circulation, 135, e927-e999.
[5]  林瑶, 李晓惠, 石琳, 杜军保. 2017年版《川崎病的诊断、治疗及远期管理——美国心脏协会对医疗专业人员的科学声明》解读[J]. 中国实用儿科杂志, 2017, 32(9): 641-648.
[6]  噬血细胞综合征中国专家联盟, 中华医学会儿科学分会血液学组. 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98(2): 91-95.
[7]  Do?an, V., Karaaslan, E., et al. (2016) Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl. Balkan Medical Journal, 33, 470-472.
https://doi.org/10.5152/balkanmedj.2016.150371
[8]  Chen, Y., Shang, S., Zhang, C., et al. (2010) He-mophagocytic Lymphohistiocytosis at Initiation of Kawasaki Disease and Their Differential Diagnosis. Pediatric Hema-tology and Oncology, 27, 244-249.
https://doi.org/10.3109/08880011003623642
[9]  Choi, J.E., Kwak, Y., et al. (2018) Differentiation between In-complete Kawasaki Disease and Secondary Hemophagocytic Lymphohistiocytosis Following Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide. Korean Journal of Pediatrics, 61, 167-173.
https://doi.org/10.3345/kjp.2018.61.5.167
[10]  Nasir, A., Al Tatari, H. and Hamdan, M.A. (2012) Very High Se-rum Ferritin Levels in Three Newborns with Kawasaki-Like Illness. Paediatrics & Child Health, 17, 201-204.
https://doi.org/10.1093/pch/17.4.201
[11]  Lerkvaleekul, B., Vilaiyuk, S., et al. (2018) Macrophage Activation Syn-drome: Early Diagnosis Is Key. Open Access Rheumatology: Research and Reviews, 10, 117-128.
https://doi.org/10.2147/OARRR.S151013
[12]  Vilaiyuk, S., Sirachainan, N., et al. (2013) Recurrent Macrophage Activation Syndrome as the Primary Manifestation in Systemic Lupus Erythematosus and the Benefit of Serial Ferritin Measurements: A Case-Based Review. Clinical Rheumatology, 32, 899-904.
https://doi.org/10.1007/s10067-013-2227-1
[13]  Kostik, M.M., Dubko, M.F., Masalova, V.V., et al. (2015) Identi-fication of the Best Cutoff Points and Clinical Signs Specific for Early Recognition of Macrophage Activation Syndrome in Active Systemic Juvenile Idiopathic Arthritis. Seminars in Arthritis and Rheumatism, 44, 417-422.
https://doi.org/10.1016/j.semarthrit.2014.09.004
[14]  Schulert, G.S., Grom, A.A., et al. (2015) Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies. Annual Review of Medicine, 66, 145-159.
https://doi.org/10.1146/annurev-med-061813-012806
[15]  Put, K., Avau, A., Brisse, E., et al. (2015) Cytokines in Systemic Juvenile Idiopathic Arthritis and Haemophagocytic Lymphohistiocytosis: Tipping the Balance between Interleu-kin-18 and Interferon-γ. Rheumatology, 54, 1507-1517.
https://doi.org/10.1093/rheumatology/keu524
[16]  Lerkvaleekul, B. and Vilaiyuk, S. (2018) Macrophage Activation Syndrome: Early Diagnosis Is Key. Open Access Rheumatology, 10, 117-128.
https://doi.org/10.2147/OARRR.S151013
[17]  Wang, W., Gong, F., Zhu, W., Fu, S., et al. (2015) Macrophage Activation Syndrome in Kawasaki Disease: More Common than We Thought? Seminars in Arthritis and Rheumatism, 44, 405-410.
https://doi.org/10.1016/j.semarthrit.2014.07.007
[18]  Latino, G.A., Manlhiot, C., Yeung, R.S., et al. (2010) Mac-rophageactivation Syndrome in the Acute Phase of Kawasaki Disease. Journal of Pediatric Hematology/Oncology, 32, 527-531.
https://doi.org/10.1097/MPH.0b013e3181dccbf4
[19]  郭莉, 卢美萍, 等. 巨噬细胞活化综合征的临床和实验室特征分析[J]. 中国当代儿科杂志, 2017, 19(2): 188.
[20]  Kang, H.R., Kwon, Y.H., Yoo, E.S., et al. (2013) Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Following Kawasaki Disease: Differentiation from Re-current Kawasaki Disease. Blood Research, 48, 254-257.
https://doi.org/10.5045/br.2013.48.4.254
[21]  Shafferman, et al. (2014) High Dose Anakinra for Treatment of Se-vere Neonatal Kawasaki Disease: A Case Report. Pediatric Rheumatology, 12, 26.
https://doi.org/10.1186/1546-0096-12-26
[22]  Servel, A.C., Vincenti, M., Darras, J.P., et al. (2012) Intravenous Immunoglobulin-Resistant Kawasaki Disease with Hemophagocytosis. Archives de Pédiatrie, 19, 741-744.
https://doi.org/10.1016/j.arcped.2012.04.016

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133